`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`UNITED THERAPEUTICS
`CORPORATION,
`
`
`
`
`
`LIQUIDIA TECHNOLOGIES, INC.,
`
`
`
`
`
`
`
`Plaintiff,
`
`Defendant.
`
`
`
`v.
`
`
`
`
`
`
`
`C.A. No. 20-755 (RGA) (JLH)
`
`
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`
`
`
`
`
`
`
`CLAIM CONSTRUCTION ORDER
`
`Having considered the parties’ Joint Claim Construction Brief (D.I. 75) and the
`
`arguments contained therein, and hearing oral argument on June 4, 2021,
`
`IT IS HEREBY ORDERED THAT, as used in the asserted claims of U.S. Patent Nos.
`
`8,593,066 (the “’066 patent”) and 9,604,901 (the “’901 patent”), the terms below have the
`
`following meanings1:
`
`Term
`
`“a process”
` ’066 patent, claims 1 and 8
`“ambient temperature”
` ’066 patent, claims 6 and 8;
` ’901 patent, claim 6
`“stored” / “storing” / “storage”
` ’066 patent, claims 6 and 8;
` ’901 patent, claim 6
`
`Construction
`plain and ordinary meaning
`
`room temperature (equal to or less than the
`range of 15°C to 30°C)
`
`plain and ordinary meaning
`
`
`1 The Court also heard argument concerning the terms “pharmaceutical batch” and
`“contacting the solution comprising treprostinil from step (b) with a base to form a salt of
`treprostinil,” appearing in claims 1 and 8 of the ʼ901 patent, but will issue its order regarding
`these terms after considering additional briefing by the parties.
`
`
`
`
`
`Liquidia Exhibit No. 1054
`IPR2020-00770 - Page 001
`
`
`
`Case 1:20-cv-00755-RGA-JLH Document 117 Filed 06/15/21 Page 2 of 2 PageID #: 8476
`
`
`
`SO ORDERED this day of June, 2021.
`
`
`
`
`
`
`
`
`UNITED STATES DISTRICT JUDGE
`
`
`
`
`
`
`2
`
`Liquidia Exhibit No. 1054
`IPR2020-00770 - Page 002
`
`